MMedication Read More Neurocrine to Buy Soleno, Nabbing Drug for Relentless Hunger DisorderApril 6, 2026 The deal is the latest in a busy year for dealmaking in the biotech industry. – eric piermont/Agence…
HHealthcare Read More This Healthcare Stock’s Revolutionary Drug Could Make Early Investors RichJuly 21, 2025 Summit Therapeutics’ leading candidate is showing promise in a key oncology market. The medicine could earn plenty of…